Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer - Wikidata - thesis-toulmin - TriplyDB

Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer

Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer

http://www.wikidata.org/entity/Q34573853

about

IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers Personalized medicine in colorectal cancer diagnosis and treatment: a systematic review of health economic evaluations.

P2860

Q36289304-24E08F6F-AB7E-4495-9D7C-DC75E861DD8F Q48130104-660E083F-2654-41FA-8D22-B4A81F9885FE

P2860

Comparative economics of a 12-gene assay for predicting risk of recurrence in stage II colon cancer

http://www.wikidata.org/entity/Q34573853

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

Comparative economics of a 12- ...... rence in stage II colon cancer

@ast

Comparative economics of a 12- ...... rence in stage II colon cancer

@en

Comparative economics of a 12- ...... rence in stage II colon cancer

@nl

type

label

Comparative economics of a 12- ...... rence in stage II colon cancer

@ast

Comparative economics of a 12- ...... rence in stage II colon cancer

@en

Comparative economics of a 12- ...... rence in stage II colon cancer

@nl

prefLabel

Comparative economics of a 12- ...... rence in stage II colon cancer

@ast

Comparative economics of a 12- ...... rence in stage II colon cancer

@en

Comparative economics of a 12- ...... rence in stage II colon cancer

@nl

P1433

Q34573853-0DB3BD57-322C-48CA-A46E-5C72ADC87F85

P1476

Q34573853-E284BFDC-9C94-41A3-BDB0-B9302672C6C3

P2093

Q34573853-082B9B28-1D33-4549-833D-760D75A04ED4

Q34573853-128DEFC4-85E8-4B4F-9375-FF7229638757

Q34573853-1E55DCAA-A0E3-4D41-AB3B-57C726691FFC

Q34573853-30A24093-E0FA-4613-B7A5-7781903415AC

Q34573853-3F5BEC18-7D75-4A6B-B128-7483B90F40B6

Q34573853-47F414C4-D7F3-4ED5-AFCD-97968F747EB8

Q34573853-53148915-AFBA-4C53-9EA1-994350EFDFAA

Q34573853-AF70FBAE-BBF7-40D2-92F0-2233277F11C3

Q34573853-C7C3F7B4-3E80-4BC2-9DB0-F791BA1B4338

Q34573853-DDE2171F-EE57-4AA9-A603-897606A7C60E

P2860

Q34573853-062AEAA2-1C48-4E68-A259-0604F30BAE5C

Q34573853-0931ECF8-3D85-43CF-AB2D-0AF61DB058D3

Q34573853-0EBDC870-6FEB-415A-AA04-6184EA6787A2

Q34573853-0F077DF5-4B68-4C43-8D6B-990F036F45AC

Q34573853-111B2024-6E3D-4C0B-90EE-58C99C34AA71

Q34573853-22ACCEA8-C07D-47EE-BF3F-3D3447EE86F9

Q34573853-23FE983C-E4F5-4696-B2D0-A1DC24761E8E

Q34573853-459DE6EE-B5C4-47B1-9508-B8E60C37CF69

Q34573853-45D2C355-77EA-4699-8F05-D9AD645C1208

Q34573853-48EB69EC-9DB6-439D-A032-77A4CEACC265

P2888

Q34573853-7D5E0CA8-91FD-4C9C-AE28-646A2EB0E7EF

P304

Q34573853-40E6612D-A0C2-41A1-A3A7-C54A7B57209B

P31

Q34573853-9D375B99-1348-43A3-ACFB-92A64A1E2D52

P356

Q34573853-885ADB8F-2C6B-46FC-B44F-89F4F20FCD3B

P433

Q34573853-67D3418C-674A-4247-8527-6DF3BCF0139D

P478

Q34573853-D18D17EE-329D-4A5C-9174-78C7BE0CD399

P577

Q34573853-98547CD9-D8A4-4B25-A0EE-EAE2B86F0038

P5875

Q34573853-45B75920-3B44-4BB4-AB2F-56E802E304BD

P698

Q34573853-9055113C-503A-4B63-B440-E6CEA7FC225D

P932

Q34573853-D579BA24-9565-4FC8-BA13-558B774C9915

P356

S40273-014-0207-1

P1433

PharmacoEconomics

P1476

Comparative economics of a 12- ...... rence in stage II colon cancer

@en

P2093

Gamini S Soori

http://www.w3.org/2001/XMLSchema#string

Geetika Srivastava

http://www.w3.org/2001/XMLSchema#string

George P Kim

http://www.w3.org/2001/XMLSchema#string

John Hornberger

http://www.w3.org/2001/XMLSchema#string

John P Kuebler

http://www.w3.org/2001/XMLSchema#string

Lindsay A Renfro

http://www.w3.org/2001/XMLSchema#string

Miroslaw A Mazurczak

http://www.w3.org/2001/XMLSchema#string

Rex B Mowat

http://www.w3.org/2001/XMLSchema#string

Robert J Behrens

http://www.w3.org/2001/XMLSchema#string

Shaker R Dakhil

http://www.w3.org/2001/XMLSchema#string

P2860

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.

Revised TN categorization for colon cancer based on national survival outcomes data.

Prospective multicenter study of the impact of oncotype DX colon cancer assay results on treatment recommendations in stage II colon cancer patients

Capecitabine as adjuvant treatment for stage III colon cancer.

Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial.

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses

Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.

Completion of therapy by Medicare patients with stage III colon cancer.

American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer.

Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity

P2888

s40273-014-0207-1

P304

1231-1243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40273-014-0207-1

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

2014-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265055041

http://www.w3.org/2001/XMLSchema#string

P698

25154747

http://www.w3.org/2001/XMLSchema#string

P932

4244576

http://www.w3.org/2001/XMLSchema#string